Codesystem Name
|
Codesystem Id
|
Version / Eingangsdatum
|
Status
|
VaccineType
|
2.16.840.1.113883.5.145
|
2012-07-24
|
definitiv
|
Level/Typ
|
Code
|
Anzeigename
|
Beschreibung
|
0-L
|
54
|
adenovirus, type 4
|
adenovirus vaccine, type 4, live, oral
|
0-L
|
55
|
adenovirus, type 7
|
adenovirus vaccine, type 7, live, oral
|
0-L
|
82
|
adenovirus, NOS
|
adenovirus vaccine, NOS
|
0-L
|
24
|
Anthrax
|
anthrax vaccine
|
0-L
|
19
|
BCG
|
Bacillus Calmette-Guerin vaccine
|
0-L
|
27
|
botulinum antitoxin
|
botulinum antitoxin
|
0-L
|
26
|
Cholera
|
cholera vaccine
|
0-L
|
29
|
CMVIG
|
cytomegalovirus immune globulin, intravenous
|
0-L
|
56
|
dengue fever
|
dengue fever vaccine
|
0-L
|
12
|
diphtheria antitoxin
|
diphtheria antitoxin
|
0-L
|
28
|
DT (pediatric)
|
diphtheria and tetanus toxoids, adsorbed for pediatric use
|
0-L
|
20
|
DTaP
|
diphtheria, tetanus toxoids and acellular pertussis vaccine
|
0-L
|
50
|
DTaPHib
|
DTaP-Haemophilus influenzae type b conjugate vaccine
|
0-L
|
1
|
DTP
|
diphtheria, tetanus toxoids and pertussis vaccine
|
0-L
|
22
|
DTP-Hib
|
DTP-Haemophilus influenzae type b conjugate vaccine
|
0-L
|
57
|
Hantavirus
|
hantavirus vaccine
|
0-L
|
52
|
Hep A, adult
|
hepatitis A vaccine, adult dosage
|
0-L
|
83
|
Hep A, ped/adol, 2 dose
|
hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
|
0-L
|
84
|
Hep A, ped/adol, 3 dose
|
hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
|
0-L
|
31
|
Hep A, pediatric, NOS
|
hepatitis A vaccine, pediatric dosage, NOS
|
0-L
|
85
|
Hep A, NOS
|
hepatitis A vaccine, NOS
|
0-L
|
30
|
HBIG
|
hepatitis B immune globulin
|
0-L
|
8
|
Hep B, adolescent or pediatric
|
hepatitis B vaccine, pediatric or pediatric/adolescent dosage
|
0-L
|
42
|
Hep B, adolescent/high risk infant
|
hepatitis B vaccine, adolescent/high risk infant dosage
|
0-L
|
43
|
Hep B, adult
|
hepatitis B vaccine, adult dosage
|
0-L
|
44
|
Hep B, dialysis
|
hepatitis B vaccine, dialysis patient dosage
|
0-L
|
45
|
Hep B, NOS
|
hepatitis B vaccine, NOS
|
0-L
|
58
|
Hep C
|
hepatitis C vaccine
|
0-L
|
59
|
Hep E
|
hepatitis E vaccine
|
0-L
|
60
|
herpes simplex 2
|
herpes simplex virus, type 2 vaccine
|
0-L
|
46
|
Hib (PRP-D)
|
Haemophilus influenzae type b vaccine, PRP-D conjugate
|
0-L
|
47
|
Hib (HbOC)
|
Haemophilus influenzae type b vaccine, HbOC conjugate
|
0-L
|
48
|
Hib (PRP-T)
|
Haemophilus influenzae type b vaccine, PRP-T conjugate
|
0-L
|
49
|
Hib (PRP-OMP)
|
Haemophilus influenzae type b vaccine, PRP-OMP conjugate
|
0-L
|
17
|
Hib, NOS
|
Haemophilus influenzae type b vaccine, conjugate NOS
|
0-L
|
51
|
Hib-Hep B
|
Haemophilus influenzae type b conjugate and Hepatitis B vaccine
|
0-L
|
61
|
HIV
|
human immunodeficiency virus vaccine
|
0-L
|
62
|
HPV
|
human papilloma virus vaccine
|
0-L
|
86
|
IG
|
immune globulin, intramuscular
|
0-L
|
87
|
IGIV
|
immune globulin, intravenous
|
0-L
|
14
|
IG, NOS
|
immune globulin, NOS
|
0-L
|
15
|
influenza, split (incl. purified surface antigen)
|
influenza virus vaccine, split virus (incl. purified surface antigen)
|
0-L
|
16
|
influenza, whole
|
influenza virus vaccine, whole virus
|
0-L
|
88
|
influenza, NOS
|
influenza virus vaccine, NOS
|
0-L
|
10
|
IPV
|
poliovirus vaccine, inactivated
|
0-L
|
2
|
OPV
|
poliovirus vaccine, live, oral
|
0-L
|
89
|
polio, NOS
|
poliovirus vaccine, NOS
|
0-L
|
39
|
Japanese encephalitis
|
Japanese encephalitis vaccine
|
0-L
|
63
|
Junin virus
|
Junin virus vaccine
|
0-L
|
64
|
leishmaniasis
|
leishmaniasis vaccine
|
0-L
|
65
|
leprosy
|
leprosy vaccine
|
0-L
|
66
|
Lyme disease
|
Lyme disease vaccine
|
0-L
|
3
|
MMR
|
measles, mumps and rubella virus vaccine
|
0-L
|
4
|
M/R
|
measles and rubella virus vaccine
|
0-L
|
94
|
MMRV
|
measles, mumps, rubella, and varicella virus vaccine
|
0-L
|
67
|
malaria
|
malaria vaccine
|
0-L
|
5
|
measles
|
measles virus vaccine
|
0-L
|
68
|
melanoma
|
melanoma vaccine
|
0-L
|
32
|
meningococcal
|
meningococcal polysaccharide vaccine
|
0-L
|
7
|
mumps
|
mumps virus vaccine
|
0-L
|
69
|
parainfluenza-3
|
parainfluenza-3 virus vaccine
|
0-L
|
11
|
pertussis
|
pertussis vaccine
|
0-L
|
23
|
plague
|
plague vaccine
|
0-L
|
33
|
pneumococcal
|
pneumococcal polysaccharide vaccine
|
0-L
|
100
|
pneumococcal conjugate
|
pneumococcal conjugate vaccine, polyvalent
|
0-L
|
70
|
Q fever
|
Q fever vaccine
|
0-L
|
18
|
rabies, intramuscular injection
|
rabies vaccine, for intramuscular injection
|
0-L
|
40
|
rabies, intradermal injection
|
rabies vaccine, for intradermal injection
|
0-L
|
90
|
rabies, NOS
|
rabies vaccine, NOS
|
0-L
|
72
|
rheumatic fever
|
rheumatic fever vaccine
|
0-L
|
73
|
Rift Valley fever
|
Rift Valley fever vaccine
|
0-L
|
34
|
RIG
|
rabies immune globulin
|
0-L
|
74
|
rotavirus
|
rotavirus vaccine, tetravalent, live, oral
|
0-L
|
71
|
RSV-IGIV
|
respiratory syncytial virus immune globulin, intravenous
|
0-L
|
93
|
RSV-Mab
|
respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
|
0-L
|
6
|
rubella
|
rubella virus vaccine
|
0-L
|
38
|
rubella/mumps
|
rubella and mumps virus vaccine
|
0-L
|
75
|
smallpox
|
smallpox vaccine
|
0-L
|
76
|
Staphylococcus bacterio lysate
|
Staphylococcus bacteriophage lysate
|
0-L
|
9
|
Td (adult)
|
tetanus and diphtheria toxoids, adsorbed for adult use
|
0-L
|
35
|
tetanus toxoid
|
tetanus toxoid
|
0-L
|
77
|
tick-borne encephalitis
|
tick-borne encephalitis vaccine
|
0-L
|
13
|
TIG
|
tetanus immune globulin
|
0-L
|
95
|
TST-OT tine test
|
tuberculin skin test; old tuberculin, multipuncture device
|
0-L
|
96
|
TST-PPD intradermal
|
tuberculin skin test; purified protein derivative solution, intradermal
|
0-L
|
97
|
TST-PPD tine test
|
tuberculin skin test; purified protein derivative, multipuncture device
|
0-L
|
98
|
TST, NOS
|
tuberculin skin test; NOS
|
0-L
|
78
|
tularemia vaccine
|
tularemia vaccine
|
0-L
|
25
|
typhoid, oral
|
typhoid vaccine, live, oral
|
0-L
|
41
|
typhoid, parenteral
|
typhoid vaccine, parenteral, other than acetone-killed, dried
|
0-L
|
53
|
typhoid, parenteral, AKD (U.S. military)
|
typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
|
0-L
|
101
|
typhoid, ViCPs
|
Typhoid Vi capsular polysaccharide vaccine
|
0-L
|
91
|
typhoid, NOS
|
typhoid vaccine, NOS
|
0-L
|
79
|
vaccinia immune globulin
|
vaccinia immune globulin
|
0-L
|
21
|
varicella
|
varicella virus vaccine
|
0-L
|
81
|
VEE, inactivated
|
Venezuelan equine encephalitis, inactivated
|
0-L
|
80
|
VEE, live
|
Venezuelan equine encephalitis, live, attenuated
|
0-L
|
92
|
VEE, NOS
|
Venezuelan equine encephalitis vaccine, NOS
|
0-L
|
36
|
VZIG
|
varicella zoster immune globulin
|
0-L
|
37
|
yellow fever
|
yellow fever vaccine
|